IL-4 therapy prevents the development of proteinuria in active heymann nephritis by inhibition of Tc1 cells

Journal of Immunology

Volumn 167, Issue 7, 2001, Pages 3725-3733

  Spicer, S T ^a   Ha, H ^a   Boyd, R A ^a   He, X Y ^a   Carter, N ^a   Tran, G ^a   Penny, M J ^a   Hodgkinson, S J ^a   Hall, B M ^a  

^a LIVERPOOL HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G1; INTERLEUKIN 4; INTERLEUKIN 4 ANTIBODY; KIDNEY ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY MRCOX 81; PROTEIN CRRY; RECOMBINANT INTERLEUKIN 3; RECOMBINANT INTERLEUKIN 4; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; HEYMANN NEPHRITIS; IMMUNOPATHOGENESIS; IMMUNOTHERAPY; LYMPH NODE CELL; LYMPHOCYTE SUBPOPULATION; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

EID: 0035478686     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.7.3725     Document Type: Article

References (66)

1. Interleukin-4 protects against a genetically linked lupus-like autoimmune syndrome
2. Immunologic determinants of susceptibility to experimental glomerulonephritis: Role of cellular immunity
3. Interleukin-4 ameliorates experimental glomerulonephritis and up-regulates glomerular gene expression of IL-1 decoy receptor
4. Immune modulation with interleukin-4 and interleukin-10 prevents crescent formation and glomerular injury in experimental glomerulonephritis
5. Self-reactive anti-class T helper type 2 cell lines derived from gold salt-injected rats trigger B cell polyclonal activation and transfer autoimmunity in CD8-depleted normal syngenetic recipients
6. Susceptibility to mercuric chloride-induced glomerulonephritis is age-dependent: Study of the role of IFN-γ
7. Production of nephrotic syndrome in rats by Freund's adjuvants and rat kidney suspensions
8. Production of nephrotic syndrome in rats by Freund's adjuvants and rat kidney suspensions
9. Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis rats
10. Anti-Fx1A produces complement-dependent cytotoxicity of glomerular epithelial cells
11. Pathogenesis of glomerular damage in glomerulonephritis
12. A new role for complement in experimental membranous nephropathy in rats
13. An evaluation of the role of complement depletion in experimental membranous nephropathy in the rat
14. Inhibition of complement regulation is key to the pathogenesis of active Heymann nephritis
15. Active Heymann nephritis in complement component C6 deficient rats
16. Role of T cells in the mediation of Heymann nephritis. II. Identification of Th1 and cytotoxic cells in glomeruli
17. + T cell depletion prevents proteinuria in active Heymann nephritis
18. Interleukin-4: A prototypic immunoregulatory lymphokine
19. - cells that make TH2 cytokines and help B cells
20. Increasing incidence of focal-segmental glomerulosclerosis among adult nephropathies: A 20-year renal biopsy study
21. 2
22. Antagonistic effects of IL-4 and interferon-γ (IFN-γ) on inducible nitric oxide synthase expression in bovine macrophages exposed to Gram-positive bacteria
23. Macrophage-inactivating IL-13 suppresses experimental autoimmune encephalomyelitis in rats
24. Interleukin-4 and interleukin-13: Their similarities and discrepancies
25. Autologous immune complex nephritis induced with renal tubular antigen. I. Identification and isolation of the pathogenetic antigen
26. Biochemical and immunological properties of rat recombinant interleukin-2 and interleukin-4
27. + suppressor T cells that are not dependent upon IL-4
28. + T cells in vitro
29. Treatment with interleukin-4 prolongs allogeneic neonatal heart graft survival by inducing T helper 2 responses
30. Interleukin 13 cloning from DA rats
31. Expression of recombinant rat interleukin-13 (IL-13) and generation of a neutralizing rat IL-13 antiserum
32. A monoclonal antibody (A6) recognizing a unique epitope restricted to CD45RO and RB isoforms of the leukocyte common antigen family identities functional T cell subsets
33. Lymphocyte subsets in Heymann nephritis
34. A repopulation assay for B and T lymphocyte stem cells employing radiation chimeras
35. Immunohistochemical localization of terminal complement component C9 in experimental allergic encephalomyelitis
36. A monoclonal antibody to a constant determinant of the rat T cell antigen receptor that induces T cell activation: Differential reactivity with subsets of immature and mature T lymphocytes
37. Analysis of cell surfaces by xenogenic myeloma-hybrid antibodies: Differentiation antigens of rat lymphocytes
38. Two subsets of rat T lymphocytes defined with monoclonal antibodies
39. The heterogeneity of mononuclear phagocytes in lymphoid organs: Distinct macrophage subpopulations in the rat recognized hy monoclonal antibodies ED1, ED2 and ED3
40. Molecular and antigenic heterogeneity of the rat leukocyle common antigen from thymocytes and T and B lymphocytes
41. The cellular basis of allograft rejection in vivo. III. Restoration of first-set rejection of heart grafts by T helper cells in irradiated rats
42. Semi-quantitative PCR for the analysis of gene expression
43. Induction of specific tolerance to allografts in rats by therapy with non-mitogenic, non-depleting anti-CD3 monoclonal antibody: Association with TH2 cytokines not anergy
44. Transfer of experimental autoimmune nephrosis in rats
45. Transfer of an autoimmune nephrosis in the rat by means of lymph node cells
46. Glomerular leukotriene synthesis in Heymann nephritis
47. Complement and monocytes are essential for provoking glomerular injury in passive Heymann nephritis in rats: Terminal complement components are not the sole mediators of proteinuria
48. Depletion of C6 prevents development of proteinuria in experimental membranous nephropathy in rats
49. C5b-9-independent glomerular basement membrane expansion in experimental membranous nephropathy
50. Induction of PHN in the C6-deficient PVG rat: Glomerular injury and proteinuria in PHN is independent of the membrane attack complex
51. Antigen-bound C3b and C4b enhance antigen-presenting cell function in activation of human T-cell clones
52. Modulation of antigen processing and presentation by covalently linked complement C3h fragment
53. Complement-immunoglobulin interactions
54. Murine interstitial nephritis. III. The selection of phenotypic (Lyt and L3T4) and idiotypic (RE-Id) T cell preferences by genes in lgh-I and H-2K characterizes the cell-mediated potential for disease expression: Susceptible mice provide a unique effector T cell repertoire in response to tubular antigen
55. + suppressor T cells which are antigen- specific and inhibit the expression of disease
56. + T cell line that mediates murine interstitial nephritis
57. Immunoregulation and TGF-Β1: Suppression of a nephritogenic murine T cell clone
58. Reversible cell damage by T-cell perforins: Calcium influx and propidium iodide uptake into K562 cells in the absence of lysis
59. IL-4 directs the development of Th2-like helper effectors
60. ILA dictates T-cell differentiation
61. Interleukin-4 and interleukin-10 attenuate established crescentic glomerulonephritis in mice
62. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease
63. Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin-10 and inteleukin-4
64. Administration of IL-4 prevents autoimmune diabetes but enhances pancreatic insulitis in NOD mice
65. Th2 immune deviation prevents active Heymann nephritis: The role of Th1 cytotoxic cells and macrophages: The 36th Australian and New Zealand Society of Nephrology annual meeting
66. Interleukin-4 therapy prevents active Heymann nephritis. The 32nd American Society of Nephrology Annual Meeting. Miami Beach, Fl